About this trial
The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).
Study Objectives:
To assess whether Qi-Gong improves physiological function in individuals with PASC.
To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.
Study Design:
If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness.
Participant Involvement:
Practice Qi-Gong three times per week for three months. Record physiological data monthly.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
PASC
above 20 y/o
Disqualifiers
Those who cannot cooperate
Severe schizophrenia
Trial design
Crossover
Treatments tested in this trial
QI-GONG and control
BehavioralQIGONG
Treatment groups
Trial outcomes
Primary outcomes
Pulmonary Function Test (Forced vital capacity)
FVC,over 80% is better
Pulmonary Function Test (FEV1)
FEV1,over 80% is better
Pulmonary Function Test (FVCFEV1)
FVCFEV1,over 80% is better
Heart rate variability
Low Frequency,40%-60%
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
POCHIWU
Lead sponsor
National Taipei University of Nursing and Health Sciences
Sponsor institution